Tick-borne infections—including Lyme disease (Borrelia burgdorferi and relapsing-fever Borrelia), rickettsioses (Rickettsia spp.), ehrlichiosis/anaplasmosis (Ehrlichia/Anaplasma), babesiosis, and regionally relevant tick-borne encephalitis virus (TBEV)—require rapid, algorithmic testing to capture early bacteremia and later seroconversion. At Southern Medical Supplies Limited (SMSL), we offer end-to-end workflows: NAAT/PCR on whole blood/CSF/biopsy for acute disease and co-infection detection; two-tier or modified two-tier Lyme serology (screening ELISA/CLIA IgM/IgG with confirmatory immunoblot/line blot); IFA/ELISA with acute–convalescent titers for rickettsial diseases; plasma/whole-blood PCR and thick/thin smear for babesiosis; and IgM/IgG (± IgG avidity) and PCR for TBEV where indicated—supported by CRP/procalcitonin, LFTs/hemolysis panels, and clear reflex algorithms for co-pathogens. Our portfolio spans molecular, ELISA/chemiluminescent immunoassay, immunoblot/IFA, microbiology, and clinical chemistry platforms sourced from a broad network of trusted partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the sensitivity, specificity, and reproducibility clinicians need for timely diagnosis, co-infection assessment, and treatment guidance.